Brachytherapy
Volume 6, Issue 1 , Pages 26-33 , January 2007

Assessment of postbrachytherapy sexual function: A comparison of the IIEF-5 and the MSEFS

  • Timothy M. Zagar

      Affiliations

    • Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY
    • Department of Urology, Mount Sinai School of Medicine, New York, NY
    • ,
  • Richard G. Stock

      Affiliations

    • Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY
    • Department of Urology, Mount Sinai School of Medicine, New York, NY
    • Corresponding Author InformationCorresponding author. Department of Radiation Oncology, Mount Sinai School of Medicine, Box 1236, 1184 5th Avenue, New York, NY 10029, USA. Tel.: +1-212-241-7502; fax: +1-212-410-7194.
    • ,
  • Jamie A. Cesaretti

      Affiliations

    • Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY
    • Department of Urology, Mount Sinai School of Medicine, New York, NY
    • ,
  • Nelson N. Stone

      Affiliations

    • Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY
    • Department of Urology, Mount Sinai School of Medicine, New York, NY

Received 25 March 2006 ,Revised 30 October 2006 ,Accepted 3 November 2006.

References 

  1. NIH Consensus Development Panel on impotence: Impotence. JAMA. 1993;270:83–90
  2. Walsh PC, Donker PJ. Impotence following radical prostatectomy: Insight into etiology and prevention. J Urol. 1982;128:492–497
  3. Stock RG, Kao J, Stone NN. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol. 2001;165:436–439
  4. Zelefsky MJ, Eid JF. Elucidating the etiology of erectile dysfunction after definitive therapy for prostatic cancer. Int J Radiat Oncol Biol Phys. 1998;40:129–133
  5. Nag S, Ellis JE, Merrick GS, et al. American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2002;54:462–470
  6. Bahnson RR, Hanks GE, Huben RP, et al. NCCN practice guidelines for prostate cancer. Oncology. 2000;14:111–119
  7. Conte HR. Development and use of self-report techniques for assessing sexual functioning: A review and critique. Arch Sex Behav. 1983;12:555–576
  8. Derogatis LR, Melisaratos N. The DFSI: A multidimensional measure of sexual functioning. J Sex Marital Ther. 1979;5:244–281
  9. Chun J, Carson CC. Physician-patient dialogue and clinical evaluation of erectile dysfunction. Urol Clin North Am. 2001;28:249–258
  10. Blander DS, Sanchez-Ortiz RF, Broderick GA. Sex inventories: Can questionnaires replace erectile dysfunction testing?. Urology. 1999;54:719–723
  11. Rosen RC, Riley A, Wagner G, et al. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–830
  12. Rosen RC, Cappelleri JC, Smith MD, et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11:319–326
  13. Stock RG, Stone NN, Iannuzzi C. Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 1996;35:267–272
  14. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol. 1994;151:54–61

PII: S1538-4721(06)00300-X

doi: 10.1016/j.brachy.2006.11.003

Brachytherapy
Volume 6, Issue 1 , Pages 26-33 , January 2007

Article Tools